Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

Abstract Background Artesunate–amodiaquine (ASAQ) and Artemether–lumefantrine (AL) are the recommended treatment for uncomplicated Plasmodium falciparum malaria in Liberia. Intermittent preventive treatment with sulfadoxine/pyrimethamine is also recommended for pregnant women. The therapeutic effica...

Full description

Bibliographic Details
Main Authors: Victor S. Koko, Marian Warsame, Benjamin Vonhm, Moses K. Jeuronlon, Didier Menard, Laurence Ma, Fahn Taweh, Lekilay Tehmeh, Paye Nyansaiye, Oliver J. Pratt, Sei Parwon, Patrick Kamara, Magnus Asinya, Aaron Kollie, Pascal Ringwald
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Malaria Journal
Subjects:
Artesunate–amodiaquine
Artemether–lumefantrine
Plasmodium falciparum
Efficacy
Molecular markers of antimalarial drug resistance
Liberia
Online Access:https://doi.org/10.1186/s12936-022-04140-7

Internet

https://doi.org/10.1186/s12936-022-04140-7

Similar Items